Key Statistics
Market Cap$17.57M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.28
52W High$1.03
52W Low$0.17
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees29
Price Performance
1 Week-24.85%
3 Month-52.98%
1 Year-76.35%
FinancialsAnnual · QuiverQuant
Revenue$5.49M
Assets$61.53M
Liabilities$24.45M
Net Income$50.73M loss
About
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biological drugs for the selective modulation of the human immune system to treat a variety of cancers, chronic infectious diseases, and autoimmune disorders. The company is headquartered in Cambridge, Massachusetts.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze CUE with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.